Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AGEN US Equity

Agenus IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1098972 · FY ends Dec 31
$8.26
+0.73 (+9.69%)
USD · as of 2026-08-19 · marketstack
6 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-188-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-188-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-08-188-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-08-138-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-118-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-2013GSchedule 13G filed — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-07-1713GSchedule 13G filed — ≥5% beneficial owner (passive) · by Invus Global Management, LLCsec.gov ↗
2026-07-138-K 8.01Other eventssec.gov ↗
2026-07-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-138-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-07-138-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-068-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.